Rheumatoid arthritis is one of the more common autoimmune diseases, affecting an estimated 50 million adults today, the main symptoms being painful swelling in the wrists, fingers, and hands as well as other joints. It is this inflammation associated with rheumatoid arthritis that if not properly treated can lead to the damage other parts of the body as a well, including but not limited to the eyes, skin, lungs, and even the heart. Currently there is no cure for arthritis, only different forms of treatment, but so far perhaps the most effective of all has been the usage of CBD.
In a recent study published by Canadian researcher Dr. Jason McDougall, a professor of pharmacology and anesthesia at Dalhousie University in Halifax, found that the joint tissue of arthritic patients to be unusually high in “CB2 receptors”. Coincidentally, the use of CBD was found to effectively fight inflammation by activating the pathways of these same CB2 receptors. Dr. McDougall theorizes that by locally administering Cannabidiol to those nerves, not only would they be able to reduce pain and inflammation, but also to begin to heal the damaged arthritic nerves as well. His research goes on to show that the CBD molecules are actually able to attach themselves to nerve receptors and “control the firing of pain signals in the joint.” These findings have led Dr. McDougall to conclude that CBD, through its combined immunosuppressive and anti-inflammatory actions, has a potent anti-arthritic effect.
CBD balms have been known to greatly reduce the level of inflammation and drastically reduce joint pain . At Johnny Apple CBD, we extract Cannabidiol (CBD) from U.S. organically grown hemp plants specifically bred to be high in CBD content and process it using only the greenest methods available. The result is the purest >99.85% CBD crystalline on the market. And because we extract from 100% legal organic hemp, Johnny AppleCBD is 100% legal in both the USA and Canada. Try it today! Visit our website www.JohnnyAppleCBD.com today to learn more.
* Russo, Ethan B.Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. 2008 Feb; 4(1): 245–259.